title: Disease-related intestinal transplant in adults: results from a single center.
abstract: Intestinal transplantation is gaining worldwide acceptance as the main option for patients with irreversible intestinal failure and complicated total parenteral nutrition course. In adults, the main cause is still represented by short bowel syndrome, but tumors (Gardner syndrome) and dismotility disorders (chronic intestinal pseudo-obstruction [CIPO]) have been treated increasingly by this kind of transplantation procedure. We reviewed our series from the disease point of view: although SBS confirmed results achieved in previous years, CIPO is nowadays demonstrating an excellent outcome similar to other transplantation series. Our results showed indeed that recipients affected by Gardner syndrome must be carefully selected before the disease is to advanced to take advantage of the transplantation procedure.
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy. Electronic address: augustola@yahoo.com.
authors: A
authors: A
authors: Lauro
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: C
authors: C
authors: Zanfi
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: A
authors: A
authors: Dazzi
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: P
authors: P
authors: di Gioia
authors: Department of Clinical Medicine, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: V
authors: V
authors: Stanghellini
authors: Center for Chronic Intestinal Failure, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: L
authors: L
authors: Pironi
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: G
authors: G
authors: Ercolani
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: M Del
authors: MD
authors: Gaudio
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: M
authors: M
authors: Ravaioli
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: S
authors: S
authors: Faenza
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: M
authors: M
authors: di Simone
authors: Liver and Multiorgan Transplant Unit, S Orsola-Malpighi University Hospital, Bologna, Italy.
authors: A D
authors: AD
authors: Pinna
mesh_terms: D000328:Adult; D000367:Age Factors; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D000077561:Daclizumab; D005260:Female; D005736:Gardner Syndrome / Q000601:surgery; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007410:Intestinal Diseases / Q000601:surgery; D007418:Intestinal Pseudo-Obstruction / Q000601:surgery; D007422:Intestines / Q000503:physiopathology / Q000637:transplantation*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D010289:Parenteral Nutrition, Total; D016016:Proportional Hazards Models; D012778:Short Bowel Syndrome / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab; D000077561:Daclizumab; C512542:thymoglobulin